Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
PetroTal Corp | SER1 | Nov 22, 2024 | 0.45 | +5.83 |
Petrus Resources ltd | 6P4 | Nov 22, 2024 | 0.95 | +1.06 |
Pets at Home Group Plc | 6P8 | Nov 22, 2024 | 3.34 | +0.42 |
Peugeot Invest | FFP | Nov 22, 2024 | 69.90 | +0.43 |
PEXA AB SER.B | FA0 | Nov 22, 2024 | 0.02 | +4.85 |
Pexip Holding | 4W9 | Nov 22, 2024 | 3.62 | +2.26 |
Peyto Exploration & Development Corp. | PXK | Nov 22, 2024 | 11.73 | +0.64 |
Pfeiffer Vacuum Technology AG | PFV | Nov 22, 2024 | 154.00 | +0.13 |
Pferdewetten.de AG | EMH | Nov 22, 2024 | 4.82 | -2.03 |
PFERDEWETTEN.DE NA NEUE | EMH0 | Nov 22, 2024 | 2.50 | -16.67 |
PFIZER INC.CDR REG.S | PFEB | Nov 22, 2024 | 7.70 | +1.32 |
Pfizer, Inc. | PFE | Nov 22, 2024 | 24.54 | +2.79 |
PGE Polska Grupa Energetyczna SA | 6PG | Nov 22, 2024 | 1.56 | +2.54 |
Pharmamar S.A. | PMRA | Nov 22, 2024 | 72.95 | -2.01 |
Pharmanutra S.p.A. | 761 | Nov 22, 2024 | 53.50 | +0.19 |
Pharmaron Beijing Co Ltd | 17Q1 | Nov 22, 2024 | 1.58 | -5.39 |
PHARMASGP HOLDING SE O.N. | PSG | Nov 22, 2024 | 23.60 | 0.00 |
Pharmaust Ltd. | ECQ | Nov 22, 2024 | 0.13 | 0.00 |
Pharming Group N.V. - ADS, each representing 10 ordinary sha | PHG | Nov 22, 2024 | 6.90 | +2.99 |
Pharming Group NV | PHGN | Nov 22, 2024 | 0.71 | -2.28 |
PHarol SGPS SA | PTCA | Nov 22, 2024 | 0.04 | 0.00 |
Pharos Energy Plc | OCS1 | Nov 22, 2024 | 0.25 | 0.00 |
Pharvaris N.V. - Ordinary Shares | 9EN | Nov 22, 2024 | 20.60 | +7.85 |
PHASE HOLO.IMAG.PHI SK-20 | L5W | Nov 22, 2024 | 0.14 | +0.35 |
PHAXIAM THERAPEUT. EO 1,- | 2E40 | Nov 22, 2024 | 1.49 | -8.02 |
PHC Holdings Corporation | 2GY | Nov 22, 2024 | 6.25 | +5.93 |
PhenixFIN | Q29 | Nov 22, 2024 | 43.60 | +1.40 |
Phenom Resources Corp | 1PY0 | Nov 22, 2024 | 0.27 | +8.87 |
Phibro Animal Health Corporation - Class A | PB8 | Nov 22, 2024 | 22.40 | +1.82 |
Phicomm AG | HBD1 | Nov 22, 2024 | 0.97 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.